Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.

MLA

Flanagan, Meghan R., et al. “Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.” Annals of Surgical Oncology, vol. 29, no. 11, Oct. 2022, pp. 7194–201. EBSCOhost, https://doi.org/10.1245/s10434-022-12088-w.

APA

Flanagan, M. R., Doody, D. R., Voutsinas, J., Wu, Q., Banda, K., Sharifi, N., Li, C. I., & Gadi, V. K. (2022). Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer. Annals of Surgical Oncology, 29(11), 7194–7201. https://doi.org/10.1245/s10434-022-12088-w

Chicago

Flanagan, Meghan R, David R Doody, Jenna Voutsinas, Qian Wu, Kalyan Banda, Nima Sharifi, Christopher I Li, and Vijayakrishna K Gadi. 2022. “Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.” Annals of Surgical Oncology 29 (11): 7194–7201. doi:10.1245/s10434-022-12088-w.